Topical application of tacrolimus ointment did not alter the cutaneous pigmentation of yucatan micropigs

International Journal of Toxicology

Volumn 18, Issue 1, 1998, Pages 19-21

  Bekersky, Ihor ^a   Boswell, Garry ^a   Ohara, Kaname ^b   Kuroda, Yoshio ^b   Sambuco, Christopher ^c  

^a ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

^b ASTELLAS PHARMA INC   (Japan)

^c Argus Research Laboratories Inc   (United States)

Author keywords

FK506 Ointment; Hypopigmentation; Micropigs; Tacrolimus Ointment

Indexed keywords

MEQUINOL; RETINOIC ACID; TACROLIMUS;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; HYPOPIGMENTATION; MALE; NONHUMAN; SKIN IRRITATION; SKIN PIGMENTATION; SWINE; TOPICAL DRUG ADMINISTRATION; TREATMENT INDICATION;

ANIMALIA; SUS SCROFA;

EID: 0032412150     PISSN: 10915818     EISSN: None     Source Type: Journal    
DOI: 10.1080/109158199225765     Document Type: Article

References (15)

1. Abu-Elmagd, K., D. Van Thiel, B. V. Jegasothy, C. D. Ackerman, S. Todo, J. J. Fung, and T. E. Starzl. 1991. FK506: A new therapeutic agent for severe recalcitrant psoriasis. Transplant. Proc. 23:3322-3324.
2. Aoyama, H., N. Tabita, M. Tanaka, Y. Uesugi, and H. Tagami. 1995. Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment. Br. J. Dermatol. 133:494-496.
3. Bird, J., and J. Montana. 1996. New approaches to atopic dermatitis. Exp. Opin. Invest. Drugs 5:1173-1180.
4. Draize, J. H., G. Woodward, and H. O. Calvary. 1944. Methods for the study of irritation and toxicity of substances applied to the skin and mucous membranes. J. Pharmacol. Exp. Ther. 82:377-390.
5. Ehlayed, M. S. 1996. Atopic dermatitis: Immunopathology and therapeutic implications. J. Bahrain Med. Soc. 8:43-51.
6. Lauerma, A. I., and H. I. Maibach. 1994. Topical FK506 - clinical potential or laboratory curiosity? Dermatology 188:173-176.
7. Nair, X. 1993. Combination of 4-hydroxyanisole and all-trans-retinoic acid produces synergistic skin depigmentation in swine. J. Invest. Dermatol. 101:145-159.
8. Nair, X., and K. Tramposh. 1991. The Yucatan miniature swine as an in vivo model for screening skin depigmentation. J. Dermatol. Sci. 2:428-433.
9. Nakagawa, H., T. Etoh, Y. Ishibashi, Y. Higaki, M. Kawashima, H. Torü, and S. Harada. 1995. Effects of tacrolimus (FK506) ointment for facial atopic dermatitis. Allergy 50:368.
10. Sambuco, C. P. 1985. Miniature swine as an animal model in photodermatology: Factors influencing sunburn cell formation. Photodermatology 2:144-150.
11. Sambuco, C. P., and D. Forbes. 1986. Miniature swine in photodermatology. In Swine in biomedical research, M. E. Tumbleson, ed. 681-687. New York: Plenum Publishing.
12. Sambuco, C. P., P. D. Forbes, R. E. Davies, and F. Urbach. 1987. Protective value of skin tanning induced by ultraviolet radiation plus a sunscreen containing bergamot oil. J. Soc. Cosmet. Chem. 38:11-19.
13. Shurpaik, J., E. Abel, E. Bauer, M. Brown, L. Drake, R. Frienkel, G. Guzzo, J. Koo, N. Lovine, N. Lowe, C. McDonald, D. Margolis, M. Stiller, B. Wintroub, C. Bainbridge, S. Evans, S. Hilss, W. Mierlowsky, C. Winslow, and J. Birnbawn. 1997. Cyclosporine as maintenance therapy in patients with severe psoriasis. J. Am. Acad. Dermatol. 36:423-432.
14. United States Multicenter FK506 Liver Study Group. 1994. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N. Engl. J. Med. 331:1110-1115.
15. Woodle, E. S., J. R. Thistlewaite, J. A. Gordon, et al. 1996. A multicenter trials FK506 (tacrolimus) therapy in refractory acute renal allograft rejection: A report of the tacrolimus kidney transplantation rescue study group. Transplantation 62:594-599.